EnteroMedics Spikes Up 20% Following FDA Approval Of Neuroblocking Obesity Device
January 14, 2015 at 10:50 AM EST
The U.S. FDA announced Wednesday that it has approved the EnteroMedics Inc (NASDAQ: ETRM) Maestro Rechargeable System for certain ...